Mirimus' mission is to change the paradigm of the current drug discovery process by developing superior preclinical RNA interference (RNAi) animal models that can predict toxicities of potential drug therapies without the actual drug itself.

Biotechnology

Mirimus

Mirimus' headquarters in NY, United States

Prem Premsrirut

Michelle Riley

James Connolly

Sean Seibel

David Eads

Giuseppe Militello

Hui-Ting Cheng

Veronica Andrews

Subree Subramanian

Linda E Amper

Rachelle P. Mendoza

Gary Yen

Edward V Quadros

Aiqun Li

Elisa Riedo

Johannes Zuber

Lukas Dow

Christopher E. Mason

Stephen Chang

Stephen Elledge

Greg Hannon

Description

People

Jobs